2010 AusBiotech Business Development Workshop and Forum
Speakers' PowerPoint Presentations
Dr Julian Clark, Walter & Eliza Hall Institute - Managing the Alliance
Dr Justin Coombs, Phillips Ormonde Fitzpatrick - International Patent "War Stories"
Joy Hewitt, Biota Holdings Ltd - Building a Valuation Model: Where to Start
Dr Phil Kearney, Merck Sharpe & Dohme - Managing the Alliance from a "Big Pharma" Perspective
Dr Anna Lavelle, CEO, AusBiotech Ltd - 2009 Year in Review
Ralph Villiger, Avance - Deal Valuation and Deal Analysis
Michaela White, Thomson Reuters - Rational and value of using databases for Business Development
Rebecca Wilson, Buchan Consulting Pty Ltd - Presentation Skills Training Workshop
Tanya Solomon, RBS Morgans Ltd - 2009 Year in Review
Download the Program
Program Overview
Wednesday 3 March
2.00pm - 4.00pm - Concurrent workshops:
- Presentation Skills Training Workshop – Rebecca Wilson, Director, Buchan Consulting Pty Ltd
- Risk Communication: Protecting your technology agenda – Dr Andrew Powell, CEO Asia BioBusiness, Singapore
4.15pm – 5.30pm
- Optional visit to BioSA Incubator, Thebarton
6.00pm -9.00pm
- Bio Innovation SA Networking Forum - Click here to register
Thursday 4 and Friday 5 March
Sessions will include:
- AusBiotech SA Branch Breakfast: "What's Really Happening Across the Ditch?" - the current landscape and emerging opportunities in New Zealand's Bioeconomy - Bronwyn Dilley, CEO, NZBIO
- Official Welcome – Dr Deborah Rathjen, Chair AusBiotech Ltd; Dr Jurgen Michaelis, CEO, Bio Innovation SA
- 2009 Year in Review - Tanya Solomon, Associate Director, RBS Morgans Limited, 2009 AFR Starmine Award Winner: Top Stock Picker for the Health Care Industry and Dr Anna Lavelle, CEO, AusBiotech Ltd
- Deal Valuation and Deal Analysis - Ralph Villiger, Partner, Avance, Co-author "Valuation in Life Sciences - A Practical Guide"
- Building a Valuation Model: where to start - Joy Hewitt, Director Business Development, Biota Holdings Ltd;
- Rationale and value of using databases for Business Development - what Google can't do for your business - Michaela White, Principal Consultant - Life Sciences, Asia Pacific, The Healthcare & Science Business of Thomson Reuters
- The US Market for Biotech-Pharma Deals - Latest trends and the impact of healthcare reform - Peter Molloy, President, SYN thesis med chem USA Inc
- Managing the Alliance - Dr Julian Clark, Walter & Eliza Hall Institute; Dr Phil Kearney, Director Licensing and External Research, Merck Sharpe & Dohme; Lusia Guthrie, CEO & Managing Director, LBT Innovations
- Update from the Frontline: a selection of international patent "war stories" - Dr Justin Coombs, Associate, Phillips Ormonde Fitzpatrick
The Conference Dinner (included in the registration fee) will be held on Thursday evening at a beachside restaurant within walking distance from the Stamford Grand Adelaide Hotel.
The final session of the conference will be the very popular “On the Couch” question and answer session which will be facilitated by Hamish Hawthorn, CEO, ATP Innovations Pty Ltd and consist of 4 speakers: Dr Deborah Rathjen, Chair AusBiotech Ltd and CEO, Bionomincs Ltd; Dr Dean Moss, General Manager Life Sciences, Uniquest Pty Ltd; Dr Ashley Bates, Head of R&D Alliances, GlaxoSmithKline Australia Pty Ltd; Tanya Solomon, Associate Director, RBS Morgans Limited. Theme for the session will be "Companies' Strategies over the Next Three Years - Future Plans and Options". Delegates will be asked to submit questions relevant to the theme, in advance and during the conference which will be put to the speakers.
The conference website will be updated with program details as they are finalised. In the meantime, please email ngreenwell@ausbiotech.org with any enquiries.
